Log In
BCIQ
Print this Print this
 

CRS3123 (formerly REP3123)

  Manage Alerts
Collapse Summary General Information
Company Crestone Inc.
DescriptionMethionyl tRNA synthetase (MetRS) inhibitor
Molecular Target Methionyl tRNA synthetase (MetRS )
Mechanism of ActionMethionyl tRNA synthetase (MetRS ) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationClostridium
Indication DetailsTreat Clostridium difficile-associated infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today